The share of COVID-19 deaths among those who are vaccinated has risen. In fall 2021, about 3 in 10 adults dying of COVID-19 were vaccinated or boosted. But by January 2022, as we showed in an analysis on the Peterson-KFF Health System Tracker, about 4 in 10 deaths were vaccinated or boosted. By April 2022, the United States Centers for Disease Control and Prevention (CDC) data show that about 6 in 10 adults dying of COVID-19 were vaccinated or boosted. Anti-vaxxers are using this data to support their claims the vaccine doesn’t work, but that is not the case.

Patients today face many choices regarding treatments and medications. While beneficial in catering to individual needs, this abundance of options often entails the daunting task of making informed decisions. Understanding the nuanced process patients undergo in choosing their healthcare strategies is crucial for healthcare providers, pharma companies, and policymakers who aim to facilitate better health outcomes.

The triumph of overcoming cancer and reaching remission is no small feat. Yet, after the battles fought and won, one might assume that patients would do everything possible to adopt the healthiest lifestyles. Paradoxically, some patients in remission don’t always prioritize their health to the degree we might expect. But why? The answer is multifaceted and deeply human.

As a patient, you expect your doctor to take the time to explain your health problems to you. You want to understand what is wrong with you, what treatment options are available, and what you can do to manage your condition. However, many patients report not getting enough time from their doctors to ask questions and get the needed information.

Value-based healthcare is an approach to healthcare delivery that aims to improve patient outcomes while controlling costs. It emphasizes measuring outcomes that matter to patients and aligning payment and incentives with those outcomes. While value-based healthcare has shown promise in many areas, its effectiveness can vary depending on several factors.

The correlation between obesity and cancer is a complex and multifaceted relationship that researchers have extensively studied. While it is important to note that correlation does not necessarily imply causation, several factors contribute to the observed association between obesity and an increased risk of developing certain types of cancer.